Castle Biosciences (CSTL) Competitors $27.53 +0.44 (+1.62%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CSTL vs. LFST, SGRY, CON, PRVA, ARDT, ADUS, PACS, WGS, NHC, and TDOCShould you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), PACS Group (PACS), GeneDx (WGS), National HealthCare (NHC), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry. Castle Biosciences vs. LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Ardent Health Partners Addus HomeCare PACS Group GeneDx National HealthCare Teladoc Health Castle Biosciences (NASDAQ:CSTL) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation. Do insiders and institutionals believe in CSTL or LFST? 92.6% of Castle Biosciences shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 7.2% of Castle Biosciences shares are owned by company insiders. Comparatively, 6.6% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer CSTL or LFST? In the previous week, LifeStance Health Group had 3 more articles in the media than Castle Biosciences. MarketBeat recorded 7 mentions for LifeStance Health Group and 4 mentions for Castle Biosciences. Castle Biosciences' average media sentiment score of 0.94 beat LifeStance Health Group's score of 0.62 indicating that Castle Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, CSTL or LFST? Castle Biosciences has higher earnings, but lower revenue than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Castle Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCastle Biosciences$311.88M2.47-$57.47M$0.20137.65LifeStance Health Group$1.21B2.31-$186.26M-$0.26-28.04 Is CSTL or LFST more profitable? Castle Biosciences has a net margin of 1.95% compared to LifeStance Health Group's net margin of -7.90%. Castle Biosciences' return on equity of 1.47% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Castle Biosciences1.95% 1.47% 1.27% LifeStance Health Group -7.90%-6.66%-4.51% Do analysts prefer CSTL or LFST? Castle Biosciences presently has a consensus target price of $39.71, indicating a potential upside of 44.26%. LifeStance Health Group has a consensus target price of $8.70, indicating a potential upside of 19.34%. Given Castle Biosciences' stronger consensus rating and higher possible upside, research analysts clearly believe Castle Biosciences is more favorable than LifeStance Health Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00LifeStance Health Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more risk and volatility, CSTL or LFST? Castle Biosciences has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Does the MarketBeat Community favor CSTL or LFST? Castle Biosciences received 79 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 64.75% of users gave Castle Biosciences an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote. CompanyUnderperformOutperformCastle BiosciencesOutperform Votes9064.75% Underperform Votes4935.25% LifeStance Health GroupOutperform Votes1126.19% Underperform Votes3173.81% SummaryCastle Biosciences beats LifeStance Health Group on 15 of the 18 factors compared between the two stocks. Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CSTL vs. The Competition Export to ExcelMetricCastle BiosciencesMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$771.03M$2.93B$5.13B$9.07BDividend YieldN/A15.63%5.08%4.23%P/E Ratio137.6616.0289.5817.17Price / Sales2.47284.461,116.12116.95Price / CashN/A472.1142.8237.86Price / Book1.895.194.774.78Net Income-$57.47M-$32.86M$120.15M$225.60M7 Day Performance-4.64%-3.01%-1.92%-1.23%1 Month Performance-4.67%2.96%11.47%3.36%1 Year Performance26.34%12.37%30.54%16.60% Castle Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CSTLCastle Biosciences2.7304 of 5 stars$27.53+1.6%$39.71+44.3%+34.4%$771.03M$311.88M137.66540Insider TradeLFSTLifeStance Health Group1.6908 of 5 stars$7.79+8.6%$8.70+11.7%-0.3%$2.98B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2423 of 5 stars$22.17+8.9%$36.56+64.9%-33.8%$2.82B$2.74B-46.2913,500CONConcentra Group Holdings ParentN/A$21.46+4.7%$28.50+32.8%N/A$2.73B$1.88B0.0011,000Gap UpPRVAPrivia Health Group2.8913 of 5 stars$21.58+3.0%$24.80+14.9%-12.6%$2.59B$1.66B209.621,102ARDTArdent Health PartnersN/A$16.88+1.1%$21.82+29.3%N/A$2.41B$5.71B0.0024,200Analyst ForecastPositive NewsADUSAddus HomeCare4.7468 of 5 stars$130.88+4.7%$133.67+2.1%+38.8%$2.37B$1.06B28.6034,846Analyst RevisionPositive NewsPACSPACS Group3.6498 of 5 stars$15.34-0.5%$39.88+159.9%N/A$2.34B$3.11B0.0032,433Analyst ForecastWGSGeneDx1.2578 of 5 stars$78.14+3.6%$59.33-24.1%+2,935.3%$2.15B$267.23M-24.251,200Insider TradeGap DownNHCNational HealthCareN/A$122.10+0.5%N/AN/A$1.89B$1.23B15.2213,123News CoveragePositive NewsTDOCTeladoc Health3.2303 of 5 stars$10.70+2.7%$12.24+14.4%-53.9%$1.84B$2.60B-1.815,600Gap Down Related Companies and Tools Related Companies LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Ardent Health Partners Alternatives Addus HomeCare Alternatives PACS Group Alternatives GeneDx Alternatives National HealthCare Alternatives Teladoc Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CSTL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts